Immunomodulatory zymosan/ι-carrageenan/ agarose hydrogel for targeting M2 to M1 macrophages (antitumoral)

Geetha Venkatachalam, Jayant Giri, Saurav Mallik, Gandarvakottai Senthilkumar Arumugam, Arulmani Manavalan, Vimal Kumar Dewangan, Mukesh Doble, Zhongming Zhao

RSC Advances · 2024 · 12 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

cells per mL) and have a higher swelling (≈250-280%). This study indicates that ZM-based hydrogel could be a potential drug carrier (Rifampicin and Levofloxacin) for targeting tumour-associated macrophages (M2).

References

22